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A B S T R A C T
Mouse maternal low protein diet exclusively during preimplantation development (Emb-LPD) is sufficient to
programme altered growth and cardiovascular dysfunction in offspring. Here, we use an in vitro model com-
prising preimplantation culture in medium depleted in insulin and branched-chain amino acids (BCAA), two
proposed embryo programming inductive factors from Emb-LPD studies, to examine the consequences for
blastocyst organisation and, after embryo transfer (ET), postnatal disease origin. Two-cell embryos were cultured
to blastocyst stage in defined KSOM medium supplemented with four combinations of insulin and BCAA con-
centrations. Control medium contained serum insulin and uterine luminal fluid amino acid concentrations
(including BCAA) found in control mothers from the maternal diet model (N-insulin + N-bcaa). Experimental
medium (three groups) contained 50% reduction in insulin and/or BCAA (L-insulin + N-bcaa, N-insulin + L-
bcaa, and L-insulin + N-bcaa). Lineage-specific cell numbers of resultant blastocysts were not affected by
treatment. Following ET, a combined depletion of insulin and BCAA during embryo culture induced a non sex-
specific increase in birth weight and weight gain during early postnatal life. Furthermore, male offspring dis-
played relative hypertension and female offspring reduced heart/body weight, both characteristics of Emb-LPD
offspring. Combined depletion of metabolites also resulted in a strong positive correlation between body weight
and glucose metabolism that was absent in the control group. Our results support the notion that composition of
preimplantation culture medium can programme development and associate with disease origin affecting
postnatal growth and cardiovascular phenotypes and implicate two important nutritional mediators in the in-
ductive mechanism. Our data also have implications for human assisted reproductive treatment (ART) practice.
1. Introduction
Undernutrition is a worldwide concern affecting not only countries
with developing and emerging economies but also populations in
countries with a high human development index [1]. Human epide-
miological studies have revealed that undernutrition during the pre-
natal period can increase the risk of developing non-communicable
diseases (NCDs) in adulthood [2,3]. Indeed, experimental research in
animal models has provided strong evidence that prenatal under-
nutrition can program the occurrence of altered phenotypes (e.g. in-
creased blood pressure) in postnatal life [3]. This unfavourable pro-
gramming is the basis for the developmental origins of health and
disease (DOHaD) hypothesis [2]. Such an adverse programming can be
induced at several developmental stages during the prenatal period,
including the preimplantation phase of embryo development [4].
In a murine model of protein restriction it was shown that dams fed
with a low protein diet (9% casein) exclusively during the pre-
implantation period (days 0–3.5 of embryonic development; Emb-LPD)
produced offspring that displayed altered phenotypes during postnatal
life, including increased postnatal growth, high blood pressure, vas-
cular dysfunction and hyperactive behavior [5–7]. This animal model of
undernutrition has also revealed that compensatory mechanisms exist
to maintain viable growth of the developing fetus by altering cellular
characteristics of the placental lineages. For instance, compared to the
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control group (18% casein), protein-restricted females (i.e. Emb-LPD)
produced blastocysts with a higher number of cells in the trophecto-
derm (TE) [8], augmented endocytic activity in TE cells [9], and in-
creased spreading capacity during in vitro outgrowth formation [8].
Later in gestation, ectoplacental cones collected at embryonic day 8
(E8.5) from Emb-LPD females and cultured in vitro for 24 h displayed
an increased spreading area along with decreased number of secondary
trophoblast giant cells [10]. Similarly, in the primitive endoderm
lineage and derivative yolk sac placenta, increased endocytic activity is
stimulated by maternal protein restriction [5,9]. These changes are
associated with an increased fetal:placental weight ratio due to devel-
opment of larger fetuses with smaller placentas [10]. These phenotypic
alterations seem to be induced at the blastocyst stage, around the time
of cell lineage determination, since recipients fed with normal levels of
protein receiving protein-restricted embryos through embryo transfer
produced conceptuses with increased weight [5].
In the Emb-LPD murine model, decreased levels of insulin in blood
and branched-chain amino acids (BCAA) in uterine luminal fluid (ULF)
were detected at the time of blastocyst formation and coincided with a
reduced blastocyst mTORC1 signal mediated through these metabolites
[8]. In vitro experiments have revealed that exposure to insulin and
amino acids (AA) during the preimplantation period can affect not only
early embryo development [11–13] but also fetal growth [14–16].
However, the possible long-term effects of fluctuations of these nutri-
tional mediators during the preimplantation period on postnatal de-
velopment are currently unknown. This type of research is critical for
the elucidation of the mechanisms behind the adverse programming of
chronic disease during prenatal undernutrition. Hence, in the present
study we test the hypothesis that insulin and/or BCAA depletion during
preimplantation embryo development can act as inductive factors of
altered phenotypes during postnatal life. Using an in vitro embryo
culture (IVEC) and embryo transfer (ET) model we provide evidence
that exposure to low levels of insulin and BCAA exclusively during
preimplantation embryo development is sufficient to alter body weight
gain and blood pressure during early postnatal life in mice.
2. Materials and methods
2.1. Animals
Outbred MF1 mice under UK Home Office Licence were bred in-
house (Biomedical Research Facility, University of Southampton) on a
0700–1900 light cycle. Experimental procedures were conducted using
protocols approved by, and in accordance with, the UK Home Office
Animal (Scientific Procedures) Act 1986 and local ethics committee at
the University of Southampton. All males and females used for embryo
production or ET were fed with standard chow and water ad libitum at
all times (i.e. mating, pregnancy and lactation).
2.2. Embryo collection
Non-superovulated virgin MF1 females (7–8.5 weeks) were mated
(1:1) overnight with MF1 males. Presence of copulation plugs was
checked the following morning and regarded as a sign of successful
mating. Plug-positive females were considered to be on embryonic day
0.5 (E0.5) at midday on the day the vaginal plug was detected.
Pregnant females were caged in groups of two to four. Mice were killed
by cervical dislocation and oviducts were immediately dissected on
E1.5 to collect two-cell embryos. Oviducts were placed in warm (37 °C)
saline solution (BR0053G, OXOID, UK) and then transferred to an
empty petri dish where they were gently flushed under a stereomicro-
scope with 0.5 ml of H6 medium supplemented with 4 mg/ml bovine
serum albumin (BSA), (A3311, Sigma, UK) [17]. Embryos were then
washed with fresh H6-BSA to remove debris.
2.3. In vitro embryo culture
Two-cell embryos were randomly allocated to different concentra-
tions of insulin and BCAA in groups of 11–15 in 30 μl drops and cul-
tured up to the blastocyst stage for 66 h. Microdrops were covered with
mineral oil (M8410, Sigma, UK) and incubated under 5% CO2 in air at
37 °C. The basic in vitro culture medium was potassium simplex opti-
mized medium (KSOM) where BSA was omitted and ethylenediamine-
tetraacetic acid (EDTA) at non-toxic concentrations (0.01 mM) was
added to allow a chemically defined milieu for embryo culture [18,19].
The control KSOM medium was supplemented with serum insulin levels
and uterine luminal fluid amino acid (AA) concentrations, including
BCAA, found in pregnant (E3.5) MF1 mice fed with normal levels of
protein (18% casein) [8]. The concentrations of insulin (1 ng/ml) and
BCAA (valine = 0.46 mM, isoleucine = 0.21 mM, leucine = 0.32 mM)
used in the control medium were termed “normal” (N-insulin + N-
bcaa) and represented 100% of the levels found in vivo. The con-
centrations of amino acids used are shown in Table 1. The control group
was compared with three experimental groups where insulin and BCAA
were either low (50%) or constant (100%), giving the following com-
binations: L-insulin + N-bcaa, N-insulin + L-bcaa, and L-insulin + N-
bcaa (Fig. 1). Our in vitro model intended to mimic our in vivo model of
protein restriction where the Emb-LPD treatment reduced maternal
serum insulin by approximately 40% and BCAA concentrations in ULF
by approximately 30% at the time of blastocyst formation (E3.5) [8]. To
remove H6-BSA medium, embryos were washed three times in their
respective culture medium before in vitro culture.
2.4. Differential cell staining in blastocysts
Differential nuclear labelling was carried out in expanded blas-
tocysts (Fig. 1) based on the protocol developed by [20] with some
modifications as previously described [21]. Briefly, zona pellucidae
were removed with warm (37 °C) acid Tyrode's solution (T1788, Sigma,
UK) followed by 15–20 min washing in H6-BSA. Zona-free blastocysts
were incubated 10 min in 10% trinitrobenzenesulfonic acid solution
(TNBS, P-2297, Sigma, UK) at room temperature. Embryos were then
washed three times with H6-PVP, incubated for 10 min in 0.4 mg/ml
goat anti-dinitrophenyl (anti-DNP) antibody (D9781, Sigma, UK) in H6-
PVP at room temperature, washed again three times with H6-PVP and
incubated in 50 μl drops of reconstituted (1:10 dilution with H6-BSA)
Low-Tox® guinea pig complement (CL4051, Cedarlane, Canada)
Table 1
Amino acid composition of control medium (N-insulin + N-bcaa).
Amino acid Concentration (mM)
Alanine 3.8
Arginine 0.2
Asparagine 0.1
Aspartic ac id 1.8
Cysteine 0.2
Glutamic acid 4.7
Glutamine 1.4
Glycine 2.7
Histidine 0.1
Isoleucine 0.2
Leucine 0.3
Lysine 0.5
Methionine 0.2
Phenylalanine 0.1
Proline 0.1
Serine 1.0
Taurine 14.7
Threonine 0.7
Tryptophan 0.06
Tyrosine 0.2
Valine 0.5
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supplemented with 4 μl propidium iodide (1 mg/ml, P4170, Sigma, UK)
for 15 min at 37 °C. After washing three times with H6-BSA, embryos
were fixed in ice-cold ethanol supplemented with 1% Bisbenzimide H
33258 (2.5 mg/ml, B2883, Sigma, UK) at 4 °C for 1 h. For cell counting,
blastocysts were washed in ice-cold fresh ethanol and mounted onto a
glass microscope slide in a ~4 μl drop of glycerol (G5516, Sigma, UK)
and coverslipped. Digital photographs of blastocysts were obtained
with an inverted epifluorescence microscope (Axiovert 200 M, Carl
Zeiss Ltd.) in a darkened room. Cell nuclei were manually counted with
the MetaMorph software (Version 6.2r6, Molecular Devices).
2.5. Embryo transfer
Embryo transfer was performed by flank laparotomy in pseudo-
pregnant MF1 recipients (7–8.5 weeks) obtained by mating with va-
sectomized MF1 males. On the day of ET, embryo recipients at E2.5
were anaesthetized by a single intraperitoneal injection of Ketamine
(50 mg/kg, Ketaset, Pfizer, UK) and Xylazine (10 mg/kg, Rompun,
Bayer, UK). Once the mouse became unresponsive to paw pinch (i.e.
pedal withdrawal reflex), eyes were covered with ophthalmic ointment
(Lacri-Lube, Allergan, Ireland) to prevent them from drying and the
flanks were shaved and cleaned with 70% alcohol. In vitro-derived
blastocysts were then washed three times with M2 medium (M7167,
Sigma, UK) and loaded into a flame-polished glass pipette with a
narrow opening. Immediately after, a flank incision through skin and
peritoneum was made of approximately 1 cm in length, and the ovary-
attached fat pad was grasped and pulled out to exteriorize the uterine
horn. The uterine horn was punctured near the utero-tubal junction
with a 26-gauge needle and after removal of the needle, the fire-po-
lished glass pipette was inserted into the resultant hole and seven em-
bryos were transferred into the uterine horn cavity with a minimal
amount of medium. The reproductive tract was then gently placed back
into the abdominal cavity, the peritoneum sutured, and the skin closed
with wound clips. The same procedure was repeated in the opposite
flank were another seven blastocysts were transferred. Following ET,
recipient females were placed individually in clean cages in a warm
room (28–30 °C) to recover from anaesthesia. Once recovered, females
were moved to a quiet room during pregnancy and lactation.
Vasectomized MF1 males were produced by exteriorizing the testes via
a midline ventral incision, followed by isolation and cauterization of
the vasa deferentia. The testes were then returned to the abdominal
cavity and the peritoneum and skin sutured. The same pre- and post-
surgery conditions used in ET were applied during vasectomy. Three
weeks after surgery males were tested with two females to confirm the
success of the vasectomy.
2.6. Offspring analysis
In the morning of the expected delivery day (i.e. 20 days pregnancy
length) pups were sexed and birthweight taken. Twenty-one days after
birth, offspring were marked by ear punching and weaned, allocated
according to sex in groups of two to four, and weighed weekly until
27 weeks of age. Systolic blood pressure was measured at postnatal
weeks 9, 15 and 21 by tail-cuff plethysmography with the Non-Invasive
Blood Pressure Monitor (NIBP-8, Columbus Instruments, Columbus,
Ohio, USA) [5,21]. A training period of 2 weeks before the actual
measurements was carried out to accustom the animals to the proce-
dure. Mice were warmed before measuring blood pressure in a warm
room (28–30 °C). Five readings with good waveforms and good overall
quality were obtained per mouse. At 27 weeks of age a glucose toler-
ance test (GTT) was performed in unrestrained conscious mice after a
15-h overnight fast [21]. Glucose was measured with a blood glucose
meter (Accu-Chek, Aviva, Roche Diagnostics GmbH, Germany) in small
drops of blood collected by tail tipping. Topical anaesthetic cream
(Lidocaine 5%, Teva, UK) was applied to the tail 20 min before starting
the procedure. Following recording of the baseline glucose level
(0 min), a glucose (G8270, Sigma, UK) solution (20%, in sterile, dis-
tilled water) was applied by intraperitoneal injection at a dose of 2 g/
kg. Glucose levels were measured 15, 30, 60, and 120 min after glucose
administration. Mice had water ad libitum during fasting and the GTT
procedure. Immediately after GTT, mice were placed in clean cages
with food and water ad libitum. Two days after GTT mice were culled
by cervical dislocation and organs (i.e. spleen, liver, left and right
kidneys, heart, and lungs) were dissected out and weighed.
2.7. Statistics
Statistical analysis was performed with the IBM SPSS Statistics
software, version 21 (IBM Corporation). Embryo production expressed
as percentage and pregnancy outcome following ET were analysed with
logistic regression. The binomial test was used to examine differences in
litter sex ratios. Embryo cell allocation variables and some ET outcome
variables were analysed with one-way analysis of variance (ANOVA). If
data did not meet the homogeneity of variance assumption (i.e.
Levene's test for homogeneity of variance, P < 0.05), a Welch ANOVA
was carried out. Postnatal data were converted to Z-scores before being
analysed with a multilevel random effects regression model to compare
treatment groups [5] and to analyse relationships between different
readouts within each treatment group. The hierarchical structure of the
data due to the mother effect was taken into consideration in the
models alongside associated factors such as litter size where appro-
priate. The developed syntax first conducts analyses in which sex is
considered a fixed effect. Since nearly all our postnatal data were af-
fected significantly by sex, a second syntax was applied in which data
were analysed separately by sex, as reported here. Of the five blood
pressure readings taken per mouse, the lowest and highest values were
discarded and the mean of the three middle values was used for sta-
tistical analysis [21,22]. Area under the curve values were calculated
for GTT data by the trapezoidal rule [23]. Data are presented as
mean ± S.E.M. unless otherwise indicated.
Fig. 1. Schematic representation of the murine experimental model used in this study.
The effects of branched-chain amino acids (bcaa) and/or insulin depletion (Low,
L = 50%) on in vitro blastocyst development and health of the resultant offspring fol-
lowing embryo transfer was studied. Two-cell embryos were in vitro cultured for 66 h
until the blastocyst stage. The control medium was termed “normal” (N) and represented
100% of the serum insulin levels and uterine luminal fluid amino acid concentrations (N-
Insulin + N-bcaa), including bcaa, found in pregnant (E3.5) mice fed with normal levels
of protein (18% casein) taken from [8].
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3. Results
3.1. Effect of depletion of insulin and/or BCAA during embryo culture on
blastocyst development and cell numbers
Reductions in insulin and/or BCAA did not affect the likelihood of 2-
cell embryos to achieve the blastocyst stage (Fig. 2A,B,C) and the re-
sultant blastocysts displayed no significant alterations in cell numbers
within trophectoderm or ICM lineages (Fig. 3A,B). However, in em-
bryos used for ET, 2-cell embryos exposed to N-insulin + L-bcaa had
1.4 times higher odds (95%CI = 1.02 to 1.9, P = 0.040) to achieve the
hatching state when compared to the control group (Fig. 2A).
3.2. Effect of depletion of insulin and/or BCAA during embryo culture on
pregnancy after transfer
Reductions in insulin and/or BCAA did not affect the likelihood of
the embryo to achieve pregnancy or development to term. Thus, ET
pregnancy rate and efficiency, litter size at term and after weaning, and
offspring gender ratio were unaffected by treatment (Table 2). This is in
agreement with the in vivo model of protein restriction (Emb-LPD)
where no significant differences in pregnancy rates and litter size were
found [5].
3.3. Effect of depletion of insulin and/or BCAA during embryo culture on
postnatal offspring growth and health
Compared to the control group, a non-sex specific increase in birth
weight was observed in pups from the groups exposed to nutrient de-
pletion. However, this difference reached statistical significance only in
offspring exposed to low concentrations of both insulin and BCAA (i.e.
L-insulin + L-bcaa) (Fig. 4A,C). After weaning, male offspring from the
L-insulin + L-bcaa group showed a higher body weight than their
control counterparts from weeks 5 to 8, but the difference lost sig-
nificance afterwards (Fig. 4B). Similarly, postnatal growth in L-insulin
+ L-bcaa females was enhanced in comparison to controls only from
weeks 4 to 6 (Fig. 4D). Weekly weight from the other two nutrient-
restricted groups (i.e. L-insulin + N-bcaa and N-insulin + L-bcaa) did
not differ statistically from the control group (Fig. 4B,D).
Fig. 2. Effect of branched-chain amino acids (bcaa) and/or insulin depletion on in vitro
preimplantation development in mice (Logistic regression). (A) Blastocyst formation
(n = number of 2-cell embryos cultured) of embryos used for ET (11–16 replicates, 2–10
females per replicate). (B) Blastocyst formation (n = number of 2-cell embryos cultured)
of embryos used for cell allocation analysis (14 replicates, 2–4 females per replicate). (C)
Representative in vitro-derived blastocysts from the control group (N-insulin + N-bcaa)
(scale bar = 100 μm). 2-cell embryos were in vitro cultured up to the blastocyst stage in
either 100% (N = Normal) or 50% (L = Low) serum insulin levels with either 100% or
50% of bcaa concentrations found in the uterine luminal fluid of well-fed mice.
Fig. 3. Branched-chain amino acids (bcaa) and/or insulin depletion did not affect cell
number (A) or cell allocation variables (B) of expanded blastocysts in mice (n = number
of blastocyst analysed) 0.14 replicates (2–4 females per replicate) (ANOVA). 2-cell em-
bryos were in vitro cultured up to the blastocyst stage in either 100% (N = Normal) or
50% (L = Low) serum insulin levels with either 100% or 50% of bcaa concentrations
found in the uterine luminal fluid of well-fed mice.
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Table 2
Embryo transfer (ET) outcome of in vitro-derived embryos subjected to different concentrations of insulin and branched-chain amino acids (bcaa) exclusively during preimplantation
embryo development.
Groupa ET pregnancy
rateb (%)
ET efficiencyc
(%)
Litter size-birthd
(No.) [Litter No.]
Dead pupse
(No.)
Litter size-weaningf
(No.) [Litter No.]
Offspring
Number
Male/Female
proportiong
N-Insulin + N-bcaa 63.2 (12/19) 24.34 ± 5.69 5.41 ± 0.81 [12] 0.50 ± 0.23 6.55 ± 0.68 [9] 58 43.79 ± 5.99
L-Insulin + N-bcaa 66.7 (12/18) 23.85 ± 5.83 5.08 ± 0.87 [12] 1.16 ± 0.47 5.87 ± 1.23 [8] 47 56.01 ± 12.89
N-Insulin + L-bcaa 61.1 (11/18) 24.90 ± 5.17 5.72 ± 0.42 [11] 1.45 ± 0.60 5.87 ± 0.58 [8] 47 36.16 ± 7.42
L-Insulin + L-bcaa 76.9 (10/13) 30.30 ± 6.04 5.50 ± 0.68 [10] 0.10 ± 0.10 6.00 ± 0.52 [9] 54 55.37 ± 5.57
Data were analysed with ANOVA (mean ± S.E.M) except where otherwise indicated.
a Two-cell embryos were in vitro culture in 100% (normal, N) or 50% (low, L) of insulin blood levels and bcaa uterine luminal fluid concentrations found in well-fed mice.
b Dams that gave birth/total number of ET sessions performed. Analysed by logistic regression.
c Pups at birth (dead and alive)/total embryos transferred. Analysed by logistic regression.
d Calculated on dams that gave birth.
e Born dead or killed by dam before weaning.
f Calculated on dams with live pups at weaning.
g Analysed by binomial test.
Fig. 4. A combined depletion of insulin and branched-chain amino acids (bcaa) during in vitro preimplantation embryo development results in the production of offspring with a non sex-
specific increase in birth weight (A,C) and early postnatal growth (B,D). Murine offspring is the result of transferring blastocysts (into well-fed embryo recipients) derived from 2-cell
embryos cultured in either 100% (N = Normal) or 50% (L = Low) serum insulin levels with either 100% or 50% of bcaa concentrations found in the uterine luminal fluid of well-fed
mice. Compared to controls (N-insulin + N-bcaa), the L-insulin + L-bcaa group showed increased birth weight and higher body weight at weeks 5–8 and 4–6 in males and females
respectively. n = offspring number derived from 8 to 9 litters. Multilevel random effect regression analysis. *P < 0.05, ♦P < 0.10 (Trend).
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Systolic blood pressure was measured non-invasively at postnatal
weeks 9, 15, and 21 and the mean value for these times recorded as
‘LIFE’ (Fig. 5A,B). In both male and female offspring the LIFE value was
higher in all three treatment groups compared with the control. How-
ever, only in male offspring, and specifically the L-insulin + L-bcaa
group, was a significantly increased systolic blood pressure recorded
both at week 9 and LIFE compared with the control group (Fig. 5A). The
subsequent readings of the L-insulin + L-bcaa male group remained
higher than the control group but it did not reach statistical sig-
nificance. Systolic blood pressure was not significantly affected in fe-
male offspring after embryo nutrient depletion (Fig. 5B).
An intraperitoneal glucose tolerance test was carried out at post-
natal week 27. Glucose levels at different time points after glucose
administration were not significantly affected in male and female off-
spring (Fig. 5C,D). Only a tendency value was observed among the fe-
male groups. As such, compared to the control group, females in the L-
insulin + N-bcaa group have a greater peak of glucose concentration
15 min after glucose injection (P = 0.056), whereas females in the L-
insulin + L-bcaa showed a lower peak of glucose concentration 30 min
after glucose treatment (P = 0.080). Area under the curve was not af-
fected in both sexes (Fig. 5C,D).
Organ weight analysis at the end of the study at postnatal week 27
did not reveal significant changes in male and female offspring
(Fig. 6A,C). Only tendency values were observed, where, compared to
the control group, males in the N-insulin + L-bcaa group had a heavier
spleen (P = 0.081) and females in the L-insulin + N-bcaa group had a
lighter right kidney (P = 0.052). Nevertheless, compared to the control
group, females in the L-insulin + L-bcaa group displayed a low heart
weight to body weight ratio (Fig. 6D). A similar trend was observed in
the N-insulin + L-bcaa female group, but the difference did not reach
statistical significance (P = 0.068). Organ weight:body weight ratios
were not affected by treatment in male offspring (Fig. 6B).
The relationship between different postnatal outcomes within each
treatment group was examined and key differences found between
treatment groups are shown in Table 3. Weaning weight positively
correlated with systolic blood pressure both at week 9 and the LIFE
score in control male and female offspring (P < 0.05), however, these
associations were lost in both the L-insulin + L-bcaa and N-insulin + L-
bcaa male and female offspring but broadly retained in the L-insulin
+ N-bcaa male and female offspring (Table 3). No relationship was
evident in controls between body weight and glucose tolerance AUC
except for weight in males at week 27 when the GTT was conducted; a
similar lack of relationship was found in the L-insulin + N-bcaa and N-
insulin + L-bcaa groups except in the latter for female weight at week
9. In contrast, in both male and especially female L-insulin + L-bcaa
offspring, body weight at different ages was commonly positively cor-
related with glucose tolerance AUC at 27 weeks of age
(P < 0.05–0.001; Table 3). Lastly, control and the single nutrient de-
pletion groups showed little relationship at different ages between
fasted, peak (15 min) or end (120 min) glucose levels measured during
the GTT at 27 weeks of age. In the L-insulin + L-bcaa offspring, how-
ever, extensive positive correlations existed between body weight at all
ages and glucose levels at 27 weeks, especially in the females
(P < 0.05–0.001; Table 3). Thus, there is evidence that in L-insulin
+ L-bcaa offspring there is disturbance in normal weight-physiology
relationships including associations between early and later postnatal
characteristics.
4. Discussion
The main objective of our study was to determine whether insulin
and/or BCAA depletion during early development of the embryo can act
as inductive factors of altered phenotypes during postnatal life. This
was primarily to test the hypothesis that depletion in these metabolites
following maternal Emb-LPD during blastocyst formation was causative
in the subsequent postnatal phenotype of offspring from the dietary
model [24]. The current IVEC-ET model, using the same MF1 mouse
strain as used in the Emb-LPD model, attempted in the control group
(N-insulin + N-bcaa) to mimic the embryo compositional environment
for both AAs detected in ULF and the physiological level of serum in-
sulin found in control diet mothers. This culture medium is quite dis-
tinct in composition to that found in KSOM+ AA with multi-fold dif-
ferences evident in the levels of many AAs [8,19] hence novel for mouse
Fig. 5. A combined depletion of insulin and branched-chain amino acids (bcaa) during in
vitro preimplantation embryo development results in the production of offspring with a
sex specific increase in blood pressure but with no significant changes in glucose meta-
bolism. Murine offspring is the result of transferring blastocysts (into well-fed embryo
recipients) derived from 2-cell embryos cultured in either 100% (N = Normal) or 50%
(L = Low) serum insulin levels with either 100% or 50% of bcaa concentrations found in
the uterine luminal fluid of well-fed mice. “LIFE” indicates the mean value of the mea-
surements done during postnatal life (i.e. at weeks 9, 15 and 21). Compared to controls
(N-insulin + N-bcaa), L-insulin + L-bcaa males showed increased systolic blood pressure
at week 9. n = offspring number derived from 8 to 9 litters. Multilevel random effect
regression analysis. *P < 0.05, ♦P < 0.10 (Trend).
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embryo culture studies yet more closely resembling the in vivo condi-
tions experienced by preimplantation embryos within the uterus.
The three experimental culture treatments only differed with re-
spect to insulin and/or combined BCAA concentrations which at 50%
reduction mimicked the conditions found in the Emb-LPD exposed
embryo environment [8]. Our reasoning that these metabolites during
preimplantation development may be the inductive factors in dietary
programming were that (i) Emb-LPD blastocysts show significant re-
duction in the growth-regulating mTORC1 signalling which is mediated
through insulin and BCAA sensing [8]; (ii) Emb-LPD blastocysts are
already programmed for longer-term changes in phenotype as evi-
denced by ET to normal fed recipients [5]. Moreover, there is also
circumstantial evidence in the literature that embryos are equipped
with insulin receptors and AA transporters and that exposure to these
metabolites cause changes in later fetal growth rate (discussed later).
Lastly, the notion that growth rate regulators are prime candidates for
preimplantation programming inductive factors is supported by the
observation that perinatal weight in offspring from Emb-LPD and LPD
(where the diet is maintained for whole of gestation) treatments
positively correlates with later adult weight and disease severity [5].
The main outcomes from the use of the IVEC-ET model were that
blastocyst development and lineage-specific cell number were not af-
fected by the depleted metabolites but that aspects of postnatal phe-
notype were, including increased birth weight and early growth rate in
both genders; increased systolic blood pressure in male offspring in
early life; no clear effect on glucose tolerance; reduced heart body
weight ratio in female offspring; and disturbance in weight-physiology
relationships. Such effects are generally most prevalent in the L-insulin
+ L-bcaa group. When compared to the Emb-LPD phenotype there are
some similarities but also distinctions. Thus, blastocyst development
rate is unaffected by Emb-LPD but trophectoderm and total cell num-
bers are increased [8]. Postnatally, birth weight is increased by Emb-
LPD and for females, this growth advantage is maintained throughout
life; systolic blood pressure is increased in both genders; and heart/
body weight ratio is reduced in female offspring [5]. Glucose tolerance
in Emb-LPD offspring was not measured as in the current study but
glucose and insulin serum levels were normal in both genders [7]. Thus,
the IVEC-ET model replicates well the Emb-LPD model in terms of
Fig. 6. A combined depletion of insulin and branched-chain
amino acids (bcaa) during in vitro preimplantation embryo de-
velopment results in the production of offspring with no sig-
nificant changes in organ weight, but slight alteration in organ
allometry. Murine offspring is the result of transfer of blastocysts
(into well-fed embryo recipients) derived from 2-cell embryos
cultured in either 100% (N = Normal) or 50% (L = Low) serum
insulin levels with either 100% or 50% of bcaa concentrations
found in the uterine luminal fluid of well-fed mice. Compared to
controls (N-insulin + N-bcaa), L-insulin + L-bcaa females
showed increased heart:body weight ratio. n = offspring number
derived from 8 to 9 litters. Multilevel random effect regression
analysis. *P < 0.05, ♦P < 0.10 (Trend).
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postnatal characteristics (birth weight, early growth, blood pressure,
heart sizing) but generally these outcomes may be less pronounced and
gender-relatedness may not be consistent. However, the blastocyst
phenotype of Emb-LPD is not replicated in the current study.
Our study is therefore the first to show that direct exposure to low
levels of both insulin and BCAA exclusively during preimplantation
period is sufficient to induce an increment in both body weight gain and
blood pressure during early postnatal life. It also gives support to our
hypothesis that insulin and BCAA are important nutritional mediators
involved in the programming of postnatal disease by protein under-
nutrition at the early embryo stage [4]. Our study further confirms in
general terms the critical relevance of the mammalian preimplantation
period as a developmental window where programming with long-term
consequences for health and disease risk can be exerted and evident in
both rodent and large animal species [5,21,22,25–34].
In a broader perspective, this periconceptional window where em-
bryo culture conditions may affect postnatal phenotype is also pertinent
to the human and assisted reproduction treatment (ART). Although
controversy exist on the role of the culture medium as determinant of
birth weight in human IVF [35–38], our experimental work here and a
new randomised control trial in the human [39], strongly indicate that
the composition of the culture medium is an important contributing
factor for birth weight variation in assisted reproduction. ART children
further display increased risk of cardiovascular dysfunction likely to
derive to their in vitro treatments rather than factors associated with
parental infertility, including relative hypertension [40–42] together
with cardiovascular remodeling during pregnancy resulting in altered
heart shape and chamber size [41,43]. Thus, across small and large
animal models, and in human ART, embryo culture conditions and
composition are critical factors determining postnatal phenotype – yet,
in clinical practice, commercial culture media composition is undi-
sclosed [38].
We consider first the short-term outcomes of our treatments that
had no effect on blastocyst phenotype, in contrast to the Emb-LPD
blastocyst phenotype. Studies in mice have shown that insulin and AA,
including BCAA, added to culture medium can exert stimulatory effects.
For instance, AA supplementation can promote blastocyst formation,
cell proliferation [44–47], glucose uptake [14] and outgrowth forma-
tion [11]. Similarly, supplementation with insulin can increase the
formation [15] and cell number of blastocysts [48,49] along with re-
duced protein degradation [50], increased protein synthesis [51–53]
and enhanced endocytosis with resultant increased protein intake
[50,54]. These positive effects of insulin and AA supplementation act
through the presence of preimplantation insulin receptors [51,55,56]
and amino acid transporters (AAT) including system L and system b0,+
AATs responsible for BCAA transport [57–59]. Furthermore, it has been
suggested that insulin can act synergistically with AA to improve em-
bryo development in vitro [60].
The absence of effect of low insulin and/or BCAA on blastocyst
phenotype in the current study suggests that these factors are not in-
ductive for the increased trophectoderm proliferation seen in the Emb-
LPD model. This is supported by the evidence that (i) non-essential AAs
rather than BCAAs may have a predominant effect on mouse embryo
proliferation in vitro [45] and that (ii) for insulin, whilst the con-
centrations used here match those used previously, the stimulatory ef-
fect has been on ICM rather than trophectoderm cell numbers [49].
Moreover, the effect of maternal Emb-LPD on increasing trophectoderm
proliferation in the mouse is not matched in the rat where trophecto-
derm cell numbers decrease [61], suggesting it is not a conserved re-
sponse across species. This view further suggests that different features
Table 3
Phenotypic correlations of offspring generated after embryo transfer of in vitro-derived embryos subjected to different concentrations of insulin and branched-chain amino acids (bcaa)
exclusively during preimplantation embryo development.
N-insulin + N-bcaa L-insulin + N-bcaa N-insulin + L-bcaa L-insulin + L-bcaa
Male [22] Female [31] Male [24] Female [21] Male [16] Female [27] Male [26] Female [23]
Blood pressure and weight at 3 weeks of age
SBP wk9 – weaning weight 0.626⁎ 0.473⁎ 0.392$ 0.721⁎⁎ 0.124 −0.193 0.312 0.026
SBP wk15 – weaning weight 0.417 0.134 0.433$ 0.121 0.465$ −0.221 0.215 0.210
SBP wk21 – weaning weight 0.514$ 0.261 0.302 0.243 −0.389 0.195 −0.038 0.160
SBP LIFE – weaning weight 0.746⁎ 0.437⁎ 0.503⁎ 0.425$ 0.145 −0.106 0.312 0.185
Glucose tolerance at 27 weeks and weight at different ages
AUC – bw wk3 0.076 −0.086 −0.276 0.101 −0.383 −0.195 0.337 0.379$
AUC – bw wk9 0.065 0.025 −0.281 0.254 −0.428 −0.470⁎ 0.072 0.546⁎
AUC – bw wk15 0.202 −0.05 −0.113 0.137 −0.344 −0.302 0.372$ 0.663⁎
AUC – bw wk21 0.352 0.079 −0.062 0.170 0.122 −0.185 0.512⁎ 0.660⁎⁎
AUC – bw fasted 0.427$ 0.255 0.015 0.118 0.264 −0.067 0.597⁎ 0.688⁎⁎
GTT dynamics at 27 weeks and weight at different ages
Fasted glucose – bw3 0.103 0.101 −0.415⁎ −0.029 −0.288 0.105 0.335 0.645⁎
GTT 15 min – bw3 0.075 0.034 −0.097 −0.200 −0.152 −0.217 0.401 0.328
GTT 120 min – bw3 −0.035 −0.209 −0.082 −0.010 −0.346 −0.103 0.362 0.563⁎
Fasted glucose – bw9 −0.079 −0.041 −0.067 −0.025 0.011 0.073 −0.020 0.765⁎
GTT 15 min – bw9 0.089 −0.026 −0.009 0.134 −0.211 −0.299 0.005 0.527⁎
GTT 120 min – bw9 0.091 0.132 −0.180 0.504⁎ −0.283 −0.198 0.107 0.604⁎
Fasted glucose – bw15 0.005 −0.075 0.009 −0.027 −0.039 0.252 0.106 0.617⁎⁎
GTT 15 min – bw15 0.131 −0.042 0.105 0.064 −0.148 −0.193 0.214 0.613⁎⁎
GTT 120 min – bw 15 0.271 0.034 −0.079 0.301 0.072 0.044 0.404$ 0.679⁎⁎
Fasted glucose – bw21 0.068 −0.265 −0.063 0.103 −0.100 0.320$ 0.226 0.620⁎⁎
GTT 15 min – bw21 0.105 0.038 0.132 0.073 0.103 −0.124 0.374$ 0.618⁎⁎
GTT 120 min – bw21 0.421$ 0.177 −0.042 0.327 0.401 0.093 0.530⁎ 0.689⁎⁎
Fasted glucose – bw fasted 0.220 −0.274 −0.033 0.171 −0.021 0.379⁎ 0.395⁎ 0.626⁎⁎
GTT 15 min – bw fasted 0.119 0.221 0.130 0.065 0.200 −0.020 0.531⁎ 0.631⁎⁎
GTT 120 min – bw fasted 0.514⁎ 0.262 0.039 0.216 0.434$ 0.127 0.498⁎ 0.650⁎⁎
Data were analysed after z-standardisation using random effects regression within each treatment group split by sex. Correlation coefficients are shown and statistically relevant
relationships are marked. bw: body weight; [ ] offspring number.
$ P < 0.1.
⁎ P < 0.05.
⁎⁎ P < 0.001.
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of the compensatory response in extra-embryonic lineages activated by
Emb-LPD treatment (see Introduction, second paragraph) may be se-
parately regulated. Thus, in an earlier study, we found that the stimu-
lation of mouse blastocyst trophectoderm endocytosis as occurring after
Emb-LPD could be induced in vitro through low BCAA concentration
(equivalent to that used here) in the presence of normalised insulin [9].
Alternative maternal environmental factors changing in response to
Emb-LPD treatment should therefore be assessed in vitro for evidence of
their role in the early programming events in this model; for example,
this could include oestrogen, glucose or other AAs or their combination
with insulin [8], or other factors found to alter in response to maternal
undernutrition in other models [62].
In contrast to the preimplantation blastocyst phenotype, we have
found that embryo culture in depleted insulin and BCAA replicates well
the postnatal phenotype programmed by Emb-LPD. How might these
long-term outcomes be so induced by periconceptional metabolite le-
vels? Increased fetus and birth weight have been reported in mice de-
rived from the transfer of blastocysts that were in vitro-exposed to in-
sulin from the 2-cell stage [15,16]. Embryo culture with amino acids is
also a positive factor in fetal development [14]. However, in the current
study, increased gestational growth occurs when preimplantation me-
tabolites are depleted. Our Emb-LPD studies show that the low insulin
and BCAA maternal environment associates with altered blastocyst
mTORC1 signalling and compensatory extra-embryonic responses that
collectively enhance maternal nutrient supply and lead to increased
fetal-placental efficiency [5,8,10]. Moreover, these extra-embryonic
responses include epigenetic modifications that can be traced back to
the preimplantation period [63]. Thus, we propose that preimplanta-
tion insulin and BCAA depletion, through activation of extra-embryonic
responses, can lead to increased gestational growth and birth weight as
shown here. Moreover, in the Emb-LPD model, after release from the
dietary challenge, the embryonic somatic lineages activate a separate
mechanism to stimulate ribosome biogenesis through increased rRNA
expression, also epigenetically regulated [64]. This latter mechanism
provides the opportunity to maximise the benefit of extra-embryonic
adaptations and forms the basis for ‘catch-up’ growth to occur, a
common feature in many developmental programming models [2]. The
resulting increased birth weight and early postnatal growth rate may
then directly associate with increased chronic disease risk in adulthood
as found in the Emb-LPD model [5]. The molecular and signalling
pathways linking preimplantation insulin and BCAA levels with the
increased fetal growth trajectory after Emb-LPD release are yet to be
defined but convergence through the mTORC1 pathway is a prime
candidate. Thus, the ribosome factor identified in stimulating ribosome
biogenesis through reducing rDNA methylation after release from ma-
ternal Emb-LPD, Rrn3 (TIF-1A), is sensitive to nutrient levels and
mTORC1 signalling [65,66]. It is also worth highlighting that, similar to
the Emb-LPD model [5], after depletion of BCAA and insulin pre-
implantation, early age body weight is a strong predictor of metabolic
health measured several weeks later, especially in female offspring. In
contrast, offspring from single or no nutrient depletion preimplantation
show no or weak relationships between body weight at any age and
glucose handling capability (Table 3). This suggests that depletion of
two key nutrients preimplantation may induce a tight co-regulation of
metabolism and body weight very early on in life. Underlying me-
chanisms warrant further investigation.
It is relevant to highlight that our postnatal data were subjected to a
robust statistical analysis in which factors such as the random mother
effect (i.e. embryo recipient) and gestational litter size were included
where appropriate and considering interpretation complications
through collinearity. However, litter size can be critical for the proper
analysis of in utero programming data from litter-bearing animals [67]
and often is ignored in the statistical analyses of DOHaD-related studies
working with polyovulatory species, which can result in type 1 errors.
Here it is also important to consider some factors that could have in-
fluenced our results. Our in vitro embryo culture was carried out under
atmospheric O2 conditions (~20%), and it is known that a low O2
environment (i.e. 5%) promotes a better utilization of AA in mouse
preimplantation embryos [68]. Also, unlike microfluidic systems where
a constant flow of medium can be regulated [69], in our static in vitro
system consumption and degradation of culture medium components
took place without renewal, hindering a constant exposure of nutrients
tested in our study. Although it remains to be determined if these re-
finements (i.e. low O2 and microfluidics) could exacerbate the postnatal
phenotype observed in our study, we believe our data come from a
robust in vitro embryo culture model.
In conclusion, our study has demonstrated that an in vitro model to
recreate the maternal metabolite conditions of low insulin and BCAA
levels generated through maternal dietary protein restriction (Emb-
LPD) are sufficient in embryo culture to induce the postnatal growth
and chronic disease characteristics previously reported for this dietary
treatment. Our work further highlights the criticality of preimplanta-
tion environment and nutrition for long-term health and disease risk
and has clear relevance to ART practice. A future goal for clinical
benefit will be to expand our understanding of the molecular, epige-
netic and signalling pathways that link preimplantation exposure with
adult phenotype and metabolism.
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